Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. Learn more about GPCR stock here.
Researchers have discovered how unstructured segments of surface proteins regulate the biological function of a cell. Their ...
New Scientist on MSN
Why Our Brains, Our Selves won the Royal Society science book prize
Sandra Knapp, chair of the judging panel for the 2025 Royal Society Trivedi Science Book Prize, explains why neurologist ...
Aquaglyceroporin Aqp10, a protein channel for water and glycerol, selectively permeates urea and boric acid due to its unique ...
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical ...
BACKGROUND: Alternative splicing plays crucial roles in normal heart development and cardiac disease by influencing protein-coding sequences, functional domains, and molecular networks. However, a ...
Need to know what happened in crypto today? Here is the latest news on daily trends and events impacting Bitcoin price, blockchain, DeFi, NFTs, Web3 and crypto regulation. Today in crypto, sources ...
IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback